Related Experiment Video

Updated: Jun 23, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
05:51

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

Forty years of vascular access

Lynda K Ball1

  • 1Northwest Renal Network (Network # 16), USA.

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association
|April 29, 2009
PubMed

Insights

The first arteriovenous Scribner shunt in 1960 initiated maintenance hemodialysis for end-stage renal disease. Vascular access innovations have since evolved significantly, with future advancements on the horizon.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Medical History

Background:

  • The advent of end-stage renal disease (ESRD) treatment necessitated reliable methods for blood access.
  • Maintenance hemodialysis emerged as a viable long-term treatment option.

Observation:

  • The first arteriovenous (AV) Scribner shunt was placed on March 9, 1960, marking a pivotal moment.
  • This innovation enabled the commencement of chronic hemodialysis.

Findings:

  • The introduction of the Scribner shunt revolutionized ESRD care by facilitating long-term dialysis.
  • Subsequent advancements have led to diverse vascular access modalities.

Implications:

  • The evolution of vascular access has dramatically improved patient outcomes in chronic kidney disease.
  • Continued innovation in vascular access is crucial for the future of nephrology and dialysis care.

More Related Videos

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique07:30

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...